2026 Statin Guidelines Expand Eligibility

In March 2026, the American Heart Association, the American College of Cardiology, and other organizations released updated clinical guidelines for managing dyslipidemia. The guidelines incorporate a 2023 risk calculator, expand the age range for statin eligibility from 40-75 to 30-79, and extend the risk horizon from 10 to 30 years. A study by the University of Pittsburgh and the University of Michigan, published in the JAMA on July 20, 2026, estimates that 87.5 million U.S. adults aged 30-79 (56.6%) are now recommended for statins, including 21.5 million newly eligible. The study analyzed data from 4,366 participants in the National Health and Nutrition Examination Survey (2017-2023). The expansion is driven by younger adults with low short-term but higher long-term risk. The guidelines emphasize shared decision-making and lifestyle changes alongside medication.